参考文献
［1］Carnero A，Lleonart M.The hypoxic microenvironment：A determinant of cancer stem cell evolution［J］.Bioessays，2016，38（Suppl 1）：S65-74.
［2］Chang L，Li C，Lan T，et al.Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin［J］.Mol Med Rep，2016，13（2）：1541-1550.
［3］Chen J，Shi X，Luo T，et al.The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis［J］.Eur J Gastroenterol Hepatol，2020，32（3）：373-377.
［4］Chen Q，Chen Z，Cao S，et al.Role of circRNAs_100395 in proliferation and metastases of liver cancer［J］.Med Sci Monit，2019，25：6181-6192.
［5］Connolly G C，Chen R，Hyrien O，et al.Incidence，risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma［J］.Thromb Res，2008，122（3）：299-306.
［6］Cruz-Ramon V，Chinchilla-Lopez P，Ramirez-Perez O，et al.Thrombosis of the portal venous system in cirrhotic vs.non-cirrhotic patients［J］.Ann Hepatol，2018，17（3）：476-481.
［7］Ding S M，Lu A L，Lu J F，et al.Macrovascular endothelial cells enhance the motility of liver cancer cells by up-regulation of MMP-3，activation of integrin/FAK signaling pathway and induction of non-classical epithelial-mesenchymal transition J Cancer，2020，11（8）：2044-2059.
［8］Erhamamci S，Reyhan M，Nursal G N，et al.Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging［J］.Rev Esp Med Nucl Imagen Mol，2015，34（5）：287-294.
［9］Fan J L，Yang Y F，Yuan C H，et al.Circulating tumor cells for predicting the prognostic of patients with hepatocellular carcinoma：A meta analysis［J］.Cell Phy Biochem，2015，37（2）：629-640.
［10］Guo W，Liu S，Cheng Y，et al.ICAM-1-related non-coding RNA in cancer stem cells maintains ICAM-1 expression in hepatocellular Carcinoma［J］.Clin Cancer Res，2016，22（8）：2041-2050.
［11］Guo W，Xue J，Shi J，et al.Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients［J］.J Proteome Res，2010，9（8）：4170-4175.
［12］Hu Y H，Lu Y X，Zhang Z Y，et al.SSH3 facilitates colorectal cancer cell invasion and metastasis by affecting signaling cascades involving LIMK1/Racl［J］.Am J Cancer Res，2019，9（5）：1061-1073.
［13］Huang K，Xie W，Wang S，et al.High SPINK1 expression predicts poor prognosis and promotes cell proliferation and metastasis of hepatocellular carcinoma［J］.J Invest Surg，2020：1-10.
［14］Kayar Y，Turkdogan K A，Baysal B，et al.EUS-guided FNA of a portal vein thrombus in hepatocellular carcinoma［J］.Pan Afr Med J，2015，21：86.
［15］Koh P S，Chan S C，Chok K S，et al.The friendly incidental portal vein thrombus in liver transplantation［J］.Liver Transpl，2015，21（7）：944-952.
［16］Lee J W，Hwang S H，Kim D Y，et al.Prognostic value of FDG uptake of portal vein tumor thrombosis in patients with locally advanced hepatocellular carcinoma［J］.Clin Nucl Med，2017，42（1）：e35-e40.
［17］Lee W C，Chou H S，Wu T J，et al.Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis［J］.Clin Proteomics，2017，14：29.
［18］Li R，Jiang X，Zhang Y，et al.Cyclin B2 overexpression in human hepatocellular carcinoma is associated with poor prognosis［J］.Arch Med Res，2019，50（1）：10-17.
［19］Li S S，Yu S L，Kao L P，et al.Target identification of microRNAs expressed highly in human embryonic stem cells［J］.J Cell Biochem，2009，106（6）：1020-1030.
［20］Lin X，Huang Y，Sun Y，et al.4E-BP1（Thr46）phosphorylation association with poor prognosis in quantitative phosphoproteomics of portal vein tumor thrombus revealed that 4E-BP1Thr46 phosphorylation is associated with poor prognosis in HCC［J］.Cancer Manag Res，2020，12：103-115.
［21］Liss M A，Chen Y，Rodriguez R，et al.Immunogenic heterogeneity of renal cell carcinoma with venous tumor thrombus［J］.Urology，2019，124：168-173.
［22］Liu F，Li F，Luo L，et al.Genetic variants in cell death pathway genes and HBVrelated hepatocellular carcinoma among a Chinese Han population［J］.Apoptosis，2017，22（8）：1035-1047.
［23］Liu F Y，Deng Y L，Li Y，et al.Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma［J］.Med Oncol，2013，30（1）：425.
［24］Liu S，Cheng K，Zhang H，et al.Methylation status of the nanog promoter determines the switch between cancer cells and cancer stem cells［J］.Adv Sci，2020，7（5）：1903035.
［25］Liu S，Guo W，Shi J，et al.MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma［J］.J Hepatol，2012，56（2）：389-396.
［26］Liu S，Zhou Z，Jia Y，et al.Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis［J］.Cancer Biol Med，2019，16（1）：147-170.
［27］Liu X，Liao W，Yuan Q，et al.TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells［J］.Oncotarget，2015，6（33）：34309-34320.
［28］Lopez J I，Pulido R，Lawrie C H，et al.Loss of PD-L1（SP-142）expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma［J］.Ann Diagn Pathol，2018，34：89-93.
［29］Nishimura T，Nishida N，Komeda T，et al.Genotype stability and clonal evolution of hepatocellular carcinoma assessed by autopsy-based genome-wide microsatellite analysis［J］.Cancer Genet Cytogenet，2005，161（2）：164-169.
［30］Pan X，Wang G.Correlations of IL-23R gene polymorphism with clinicopathological characteristics and prognosis of hepatocellular carcinoma patients after interventional therapy［J］.Genomics，2019，111（4）：930-935.(https://www.daowen.com)
［31］Peng Y，Li Y，Tian Y，et al.PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma［J］.J Cancer，2018，9（13）：2389-2396.
［32］Poddar N，Avezbakiyev B，He Z，et al.Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis［J］.J Gastrointest Cancer，2012，43（3）：486-489.
［33］Saito M，Seo Y，Yano Y，et al.Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules：a case report［J］.Ann Hepatol，2013，12（6）：969-973.
［34］Sharma P，Kumar R，Jeph S，et al.18F-FDG PET-CT in the diagnosis of tumor thrombus：can it be differentiated from benign thrombus［J］.Nucl Med Commun，2011，32（9）：782-788.
［35］Tang Y，Liu S，Li N，et al.14-3-3zeta promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1alpha［J］.Oncotarget，2016，7（13）：15854-15867.
［36］Tang Y，Yu H，Zhang L，et al.Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum［J］.Chin J Cancer Res，2014，26（5）：588-595.
［37］Tang Y，Zhang Y，Wang C，et al.14-3-3zeta binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells［J］.Cancer Med，2018，7（11）：5543-5553.
［38］Wang D，Zhang X，Lu Y，et al.Hypoxia inducible factor 1alpha in hepatocellular carcinoma with cirrhosis：Association with prognosis［J］.Pathol Res Pract 2018，214（12）：1987-1992.
［39］Wang D，Zhu Y，Tang J，et al.Integrative molecular analysis of metastatic hepatocellular carcinoma［J］.BMC Med Genomics，2019，12（1）：164.
［40］Wang J，Wu S，Huang T.Expression and role of VEGF-A and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma［J］.Exp Ther Med，2018，15（6）：5450-5456.
［41］Wang J，Zhu C P，Hu P F，et al.FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition［J］.Carcinogenesis，2014，35（11）：2576-2583.
［42］Wang X M，Lu Y，Song Y M，et al.Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus［J］.Nat Commun，2020，11（1）：739.
［43］Warsow G，Hubschmann D，Kleinheinz K，et al.Genomic features of renal cell carcinoma with venous tumor thrombus［J］.Sci Rep，2018，8（1）：7477.
［44］Wu G，Zheng K，Xia S，et al.MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and beta-catenin pathway in hepatocellular carcinoma［J］.J Clin Cancer Res，2016，35（1）：89.
［45］Xia L，Mo P，Huang W，et al.The TNF-alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis［J］.Carcinogenesis，2012，33（11）：2250-2259.
［46］Yang P，Li Q J，Feng Y，et al.TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma［J］.Cancer Cell，2012，22（3）：291-303.
［47］Yang Y，Chen L，Gu J，et al.Recurrently deregulated lncRNAs in hepatocellular carcinoma［J］.Nat Commun，2017，8：14421.
［48］Yang Y，Zhou Y，Lu M，et al.Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma［J］.Mol carcinog，2012，51（7）：515-521.
［49］Ye L Y，Chen W，Bai X L，et al.Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis［J］.Cancer Res，2016，76（4）：818-830.
［50］Ye P，Wang T，Liu W H，et al.Enhancing HOTAIR/MiR-10b drives normal liver stem cells toward a tendency to malignant transformation through inducing epithelialto-mesenchymal transition［J］.Rejuvenation Res，2015，18（4）：332-340.
［51］Yuan K，Xie K，Lan T，et al.TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of beta-catenin［J］.Cell Death Differ，2020，27（4）：1355-1368.
［52］Zhang H，Ye J，Weng X，et al.Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma［J］.Cancer Genet，2015，208（10）：482-491.
［53］Zhang J，Pan Y F，Ding Z W，et al.RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription［J］.Oncogene，2015，34（12）：1575-1583.
［54］Zhang J P，Zeng C，Xu L，et al.MicroRNA-148a suppresses the epithelialmesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling［J］.Oncogene，2014，33（31）：4069-4076.
［55］Zhang J P，Zhu Y，Liu Y J，et al.Temporary filters and liver mobilization technique improve the safety and prognosis of radical nephrectomy and inferior vena cava thrombectomy in renal cell carcinoma with subdiaphragmatic thrombosis［J］.Urol Int，2013，91（3）：279-284.
［56］Zhao B，Lu J，Yin J，et al.A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma［J］.Liver Int，2012，32（9）：1451-1459.
［57］Zhou L，Rui J A，Wang S B，et al.Risk factors of microvascular invasion，portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma［J］.Hepato gastroenterology，2014，61（134）：1696-1703.
［58］王维维，王振猛，刘耀阳，等.肝细胞癌患者外周血Th17细胞水平的变化及其与肿瘤进展的关系［J］.中华肿瘤杂志，2010，32（10）：757-761.
［59］王艳，张恒辉，陈衍辉，等.白细胞介素-28B基因多态性与原发性肝细胞肝癌的关系［J］.中华预防医学杂志，2012，46（6）：527-532.